🇺🇸 FDA
Pipeline program

METRONIDAZOLE, MOLGRAMOSTIM, Saline Solution Basi 9 mg/ml solution for infusion, FOSFOMYCIN

2025-GMF-1

Phase 1 small_molecule active

Quick answer

METRONIDAZOLE, MOLGRAMOSTIM, Saline Solution Basi 9 mg/ml solution for infusion, FOSFOMYCIN for peritonitis is a Phase 1 program (small_molecule) at Lacuna Pharma Pty Ltd with 1 ClinicalTrials.gov record(s).

Program details

Company
Lacuna Pharma Pty Ltd
Indication
peritonitis
Phase
Phase 1
Modality
small_molecule
Status
active

Clinical trials